There are many asbestos testing tools that you can use to do this procedure. Asbestos testing is always regarded as the protection against a killer disease because asbestos is a fragile material that can cause havoc in a matter of seconds if proper attention is not taken to the asbestos materials in our house.
Many people like doing their asbestos testing by themselves, basically because the testing procedure is easy to learn. It can also be the most dangerous thing to do too. The testing only require that you get the testing kit and follow the user’s manual in doing your home testing. I in particular will not risk my health and that of my family in doing my home asbestos testing by myself because I might make mistake in the readings which will later cause trouble at home. I will prefer to get a professional in doing the checking for me and pay him for his service. This way, I will be rest assured that my asbestos ceiling will not fall on our head while are sleeping.
The testing kit for asbestos checking can be bought in any home stores and used to test a house properly before you and your family moved into the house, especially if it is a house that has been build since 70′s or 80′s. The proper asbestos testing of the building will allow us to determine which of the asbestos should be changed and which of them needs renovations. scaffolding Asbestos is made from materials which are naturally occurring in nature. This type of material is not stable. This is why it is very important to do thorough asbestos testing of the building before moving into it.
An expert once said that asbestos is not dangerous to human, in as much as they are in good condition, but will turn otherwise when the quality of the material used in making the asbestos begin to deteriorate. This will now allow the dangerous fibers to move into the air where it can be inhales and cause havoc to humans. The inhales asbestos substance can cause cancer of the lungs.
You won’t see it as a big deal to hire a professional to carry out your asbestos testing, if you the type of person that like things to be done in a proper way. And this asbestos testing should be done periodically to maintain the quality of the asbestos materials in our house. Many people are already diagnosed for lung cancer caused by asbestos. Be sure you do thorough test on any asbestos material in your house before to check into it.
Posts tagged ‘Testing’
(1888PressRelease) November 2010 is National Lung Cancer Awareness Month. Jamey Gelina, A radon specialist with Air Quality Control Agency of Denver Colorado, suggests that all homes should be tested for radon gas. Radon is the second leading cause of lung cancer, so Lung Cancer Awareness Month is an ideal time to test. If radon levels are 4.0 or higher, a radon mitigation system will fix the problem.
Denver, CO – According to The Environmental Protection Agency, radon gas is the second leading cause of lung cancer. Health agencies throughout the United States are urging Americans to test their homes for this deadly gas during National Lung Cancer Awareness Month. This year, November has been designated as the month to take action to prevent lung cancer.
About a year ago, The World Health Organization announced a new action level of 2.7 pCi/l for indoor radon. This is a 32% reduction from the previously accepted limit of 4.0. This new guideline was prompted by a recent compilation of studies submitted by scientists throughout the World which conclusively point to radon as the second leading cause of lung cancer next to smoking. Based on the new 2.7 threshold, millions of homes will require radon remediation work to reduce radon levels.
Each year, hundreds of thousands of deaths throughout the World are caused by exposure to radon. This new plan of action by the World Health Organization will save millions of lives by prompting homeowners toward radon reduction. More than 100 scientists from 30 countries participated in the World Health Organization International Radon Project and assisted in the publishing of the Handbook on Indoor Radon which was released earlier this month. The book is a useful resource for concerned homeowners or anyone who wants to learn more about the toxic carcinogen known as radon. It outlines the years of research and the very conclusive findings that have triggered a push for stricter legislation and construction practices that will reduce the risk of lung cancer from indoor radon exposure.
“All homes should be tested for radon regardless of the geographic location or type of construction. Since radon gas cannot be detected by human senses, the only way to know if a home has a radon problem is to conduct the test,” according to Jamey Gelina, President of Air Quality Control Agency; one of North America’s leading radon mitigation companies. His Agency has fixed radon problems in over 20,000 buildings and houses. “We have performed mitigation work for countless families who have been victims of radon-induced lung cancer which could have been prevented if they had been advised of radon testing before they purchased their homes,” Mr. Gelina added. Jamey has worked with homeowners across the country to help them reduce their exposure to radon including Colorado, Wisconsin, Minnesota, Michigan, Indiana, Kentucky, Pennsylvania, Maryland, New York, Connecticut, and Massachusetts. “Radon problems are not isolated to these areas. Elevated radon levels have been found in every state in the U.S.” Gelina added.
The good news is that radon testing is easy and inexpensive. When elevated levels are detected, there are proven remediation methods that can reduce the radon to acceptable levels. Take advantage of Lung Cancer Awareness Month (November 2010) as an opportunity to get your home tested for this silent killer. The health of your family could be at risk, and the only way to know is to test. Learn more about radon gas, the health effects associated with exposure, and how to reduce the levels within your home.
Breast cancer appears when cell from the breast tissue form a tumor of malign type. Unlike the benign type tumors, the cells of a malign type tumor grow in a way that makes them uncontrollable and life-threatening for the person who has them. Within the malign type of tumors associated there different other categories – mostly depending on where they are located. Two of the most common categories of breast cancer are in situ cancers and the invasive cancers. While in situ cancers are located within the glands for milk production (also called lobules) or the ducts that connect those to the nipple, invasive breast cancers affect not only lobules and ducts in the breast but also the rest of its tissue. Depending on how much an invasive cancer has spread, it can be categorized as a local-stage, regional-stage, or distant-stage. Another major difference between these categories comes from their probability to be cured, which is decreasing from one category to another, starting with in situ having very high chances for patient’s recovery and ending with the distant-stage one as the one with the lowest chances for recovery.
Statistics from the American Cancer Society and the National Cancer Institute indicate that almost 25 percent of US women diagnosed with cancer suffer from breast cancer. Additionally, they estimated a number of 207,090 new female cases and 39,840 deaths caused by female breast cancer for 2010. However, looking at the survival rates represents a more optimistic point of view. The numbers increased over time and they are currently estimated to be 89% at five years after diagnosis, 82% after 10 years, and 75% after 15 years.
Since breast cancer is curable in its initial stages, it is crucial for it to be diagnosed as early as possible. There is a large variety of methods that can be used for breast cancer testing purposes, including biopsy, MRI (magnetic resonance imaging) scans, CT (computerized tomography) scans or CAT (computerized axial tomography) scans, blood test, bone scans, mammograms, and ultrasounds. Other breast cancer testing methods that have become more and more commonly used in the recent years include approaches such as the genetic tests. All these have to be accompanied by the opinions and advices of specialized doctors in order to ensure both the adequacy of the diagnosis and the increase of chances for positive responses to prescribed treatment.
Screening is another form of testing that is done without the patient’s having any of the breast cancer symptoms. It can play a crucial role in fighting against a breast cancer because it identifies the disease’s cause in a stage in which the cells form nothing but an abnormal tissue that can be rapidly addressed and can prevent the manifestation of cancer symptoms and the spread of the disease to other tissues and organs. This form of testing is encouraged more and more often and as a preliminary testing, its results are relevant but not conclusive, which is why a positive screening results leads to additional tests being performed.
Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umbrella of molecular diagnostics include first-generation amplification, DNA probes, fluorescent in-situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors and molecular labels, and gene expression profiling using microarrays. These technologies are improving the discovery of therapeutic molecules for cancer, the screening, diagnosis and classification of cancer patients, and the optimization of drug therapy. This Company Publications report describes the specific segment of the in vitro diagnostics (IVD) market known as molecular diagnostics (MD), with a specialization in the MD tests for cancer. In the current medical diagnostics market, molecular diagnostics for cancer testing offers one of the brightest areas for growth and innovation. The confluence of breakthroughs in genomics, proteomics, and the development of microarray devices to measure analytes in the blood and various body tissues, has led to this revolutionary market segment offering the power of advanced analytical techniques to the diagnosis and treatment of cancer. This report analyzes the size and growth of the molecular diagnostics market in its applications for cancer detection and therapy, examining the factors that influence the various market segments and the dollar volume of sales, both in the United States and worldwide.
Table of Contents : 1. Overview 8 1.1 Statement of Report 8 1.2 About This Report 8 1.3 Scope of the Report 9 1.4 Objectives 9 1.5 Methodology 10 1.6 Executive Summary 11
2. Introduction to Molecular Diagnostics 15 2.1 Opening-up of Opportunities in Molecular Diagnostics 15 2.2 Impact of the Human Genome Project on Molecular Diagnostics 17 2.3 Considerations for Molecular and Clinical Diagnostics 17 2.4 Molecular Diagnostics in the Post-Genomic Era 20 2.5 Advances in Molecular Diagnostics Technologies 21 2.6 Oligonucleotide Array Platforms 23 2.7 Emerging Cancer Personalized Medicine Market 23 2.7.1 Predictive Cancer Molecular Diagnostics 25 2.8 Companion Tests for Drug Development 26 2.9 Opportunities for IVDMIA Companies 28
3. Cancer Diagnostics Molecular Testing Market 29 3.1 Market Description 33 3.1.1 Market Overview 33 3.1.2 Tumor Markers 34 3.1.3 Molecular Diagnostic Markers 40 3.1.4 Competitive Landscape 41 3.1.5 Sales and Marketing Strategies for Cancer Tests 44 3.1.5.1 North American Market 45 3.1.5.2 International Markets 46 3.1.5.3 Europe 46 3.1.5.4 Asia-Pacific 47 For more information, please visit :
http://www.aarkstore.com/reports/Molecular-Diagnostics-in-Cancer-Testing-82521.html
Contact: Sanaa
Ph.No.91927282585
Tel. No. +912227453309
Email:jenniffer@aarkstore.com
URL:http://www.aarkstore.com/
As much as the world needs to focus on how to improve the quality of air outdoors indoor air quality is almost more important because people generally spend most of their time inside. If the indoor air quality isn’t clean our health can deteriorate rapidly and we may not even know because we are so used to our environment some dangers are hidden.
For example, when a pipe bursts or a window breaks we see it and fix it. However, there are other indoor hazards we can’t see that unless we test for them we would never know they exist until it’s too late.
A prime example: radon.
Radon is an extremely toxic invisible natural gas which originates through uranium decay found in all soils and enters homes through various cracks in the foundation, many of which are unnoticeable to the naked eye. Depending on soil composition under the house, weather, and ventilation most homes have some level of radon, which usually effects the basement and the floor above it. The fact most people don’t realize is the only level that is safe is no radon. Aside from that less exposure is obviously better.
According to the Environmental Protection Agency (EPA) radon’s carcinogenic character makes it the leading cause of lung cancer in the US behind smoking killing more than 20,000 a year. In 2005 the Surgeon General issued a Health Advisory urging Americans to investigate how much radon their homes are accumulating but its unclear if the public has taken the issue seriously.
Part of the reason may be uncertainty of how to test. Here are some options and suggestions:
The Prime Minister, Gordon Brown, announced in his key speech at this year’s Labour Party conference that he plans to bring in speedier testing for cancer in patients showing symptoms of the disease. This will mean earlier diagnosis and earlier treatment, and could potentially save thousands of lives. This promise is building upon what the NHS has already achieved since it received extra funding and brought down the age for breast cancer screening, which has already made a difference to many women’s lives.
In his speech, Gordon Brown pledged to “finance a new right for cancer patients to have diagnostic tests carried out, completed and with results – often same day results – within one week of seeing your GP. That is our early diagnosis guarantee, building on our current guarantee of only two weeks wait to see a specialist.” The Labour Party promises to meet this target by 2014.
Initially the proposal will be implemented for lung, colorectal and ovarian cancers, with other cancers being brought into the service within 5 years. Funding which has previously been used for making improvements to hospital buildings will now be used to provide more diagnostics equipment within GP surgeries and community hospitals, including CT scanners.
So how will this be implemented? Leading cancer expert, Professor Mike Richards, will be leading the new initiative and has stated that it will involve new roles for nurses who will play an important role in carrying out many of the tests, including endoscopies and ultrasounds. The investment in the initiative will create further training opportunities for nurses and could create more nurse jobs. Nursing jobs could also involve raising more awareness of cancerous symptoms, such as unexpected weight loss, changes in bowel habits, persistent coughing or noticeable changes to a mole or wart. This will build upon the nurse’s role in cancer care as rehabilitative carer, where they address rehabilitation issues for patients in teaching, counseling and guidance.
However, there is a fear that the new responsibilities could add pressure to nurses who are already buckling under the strain of a large workload. It could prove challenging to implement the gold standard of clinical examination, ultra sound and pathology in the shorter time frame, bringing into question the quality of the diagnosis as well as the speed.
The new early diagnosis will benefit those patients who show some cancerous symptoms but do not fulfill all the conditions for immediate referral to a specialist. For example, if a young woman found a small lump in her breast, she is below the common age for breast cancer, so may not be referred to a specialist so quickly. The new scheme will be particularly helpful in detecting ovarian cancer, which can be hard to spot as it presents indistinct symptoms. The chief executive of Ovarian Cancer Action, Peter Reynolds, has stated that most women with ovarian cancer were currently diagnosed with the disease at a later stage, making treatment harder and bringing the success rate down.
